Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2024-11-25 Regulatory Filings
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the schedule of an investor/analyst meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and states that the company officials will meet investors/analysts and refer to publicly available documents. There is no financial data, report content, or detailed presentation included. The document is an announcement of an upcoming event rather than a report or transcript. Given the nature of the content, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance communication.
2024-11-25 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the outcome of resolutions passed by the company's board of directors by circulation. The resolutions pertain to the allotment of shares under ESOP and RSU plans, with and without bonus elements. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is an announcement of a corporate action (share allotment under employee stock plans) rather than a detailed financial report or a full filing. The document length is short (1969 characters), and it does not contain financial statements or detailed analysis. It is not a report itself but an update on a capital-related event. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-11-22 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the expansion of Indegene's global delivery network with a new center in Hyderabad. It is addressed to stock exchanges pursuant to SEBI regulations and includes a summary of the company's business and recent recognitions. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The document is an announcement of a corporate development rather than a financial report or management discussion. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a regulatory filing or a voting result announcement. The content aligns best with a Capital/Financing Update (CAP) as it relates to company expansion and operational growth announcements, which often fall under capital or strategic updates. The document length is about 4808 characters, which is consistent with a press release or announcement rather than a full report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-11-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of an investor/analyst meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and states that the company officials will meet investors/analysts and refer to publicly available documents. There is no financial data, no detailed presentation, no report attached or published, and no detailed discussion of financial results. The document is essentially an announcement of an event related to investor relations, not a report or transcript. Given the short length (1802 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other categories like Investor Presentation or Call Transcript. Therefore, the classification is RNS with high confidence.
2024-11-13 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about resolutions proposed to be passed by circulation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resolutions pertain to allotment of shares under ESOP and RSU plans. The document is short (1687 characters) and serves as an announcement of corporate actions related to share allotment. It does not contain financial statements or detailed financial data, nor is it a report or presentation. The content fits best under Capital/Financing Update (CAP) as it relates to share allotment under employee stock plans, which is a capital structure change update.
2024-11-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the schedule of meetings with investors and analysts. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of material events. The content is an announcement of an upcoming investor/analyst meeting, not the meeting materials or transcript itself. The document length is short (1980 characters), and it does not contain financial data, report content, or detailed presentations. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about an event related to investor relations and compliance disclosures, not a report or presentation.
2024-11-08 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.